通过金属有机框架纳米粒子加强反意义寡核酸介导的抗瘤免疫力
Julia A Nowak1, Ezra Cho1, Meredith A Davis1
1Department of Biomedical Engineering, Boston University, Boston, Massachusetts 02215, United States.
Nano letters
|February 19, 2026
概括
金属有机框架 (MOF) 保护并提供反感性寡核酸 (ASO),以减少瘤中的PD-L1表达. 这种新型的输送系统增强了抗瘤免疫力,改善了生存率,克服了当前治疗方法的局限性.
科学领域:
- 生物技术是生物技术.
- 纳米技术 纳米技术
- 免疫学 免疫学 免疫学
背景情况:
- 瘤编程死亡 - - 一个 (PD-L1) 的过度表达阻碍了免疫反应.
- 目前针对PD-L1的抗体疗法受到瘤透性和脆弱性的限制.
- 反感性寡核酸 (ASOs) 降低PD-L1,但遭受快速降解和不良传递.
研究的目的:
- 开发一种针对PD-L1.1的反感性寡核酸 (ASO) 的新型输送系统.
- 为了克服ASO降解,清除和瘤吸收不良的局限性.
- 通过MOF介导的ASO输送来增强抗瘤免疫力和治疗结果.
主要方法:
- 在NU-1000金属有机框架 (MOF) 中加载各种PD-L1特定的ASO.
- 评估ASO从MOF持续释放长达7天的情况.
- 评估三阴性乳腺癌和黑色素瘤模型中的PD-L1减少.
- 研究免疫细胞刺激,包括树突细胞激活和T细胞增殖.
- 测量瘤亡 (caspase-3表达) 和体内生存率.
主要成果:
- MOF封装持续ASO释放长达7天时间.
- 在三阴性乳腺癌和黑色素瘤模型中观察到PD-L1表达的减少.
- 实现了树突细胞刺激和增强的T细胞增殖.
- 瘤卡斯帕-3表达的增加和改善的体内生存率被证明.
- 通过MOF介导的ASO输送有效调节了瘤细胞和免疫细胞.
结论:
- 金属有机框架 (MOF) 提供了一个强大的平台来保护和提供反意义寡核酸 (ASO).
- 这一策略使持续的ASO释放成为可能,减少了剂量频率,并绕过了序列修改的需要.
- 以MOF为媒介的ASO传递提供了一种广泛适用的方法,用于向瘤基因并增强抗瘤免疫力.
相关概念视频
Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


